Varanasi, developed a new tool to detect kidney disease. The team created a paper microchip device. The device is cheap and ...

Fapon, a global leading life sciences company, is excited to participate in the upcoming MEDICA 2024 International Trade Fair ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

The molecular sensing technology can quickly analyze genes and pathogens, cutting diagnosis times to a matter of hours.

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...

Medically reviewed by Soma Mandal, MD A vitamin D test is a blood test that measures the level of vitamin D (calciferol) in ...

It provides a more precise prediction than currently available of how serious the case is by focusing on autoantibodies in ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...